Global Pharmaceutical Excipients for Non-injection Market Research Report 2025(Status and Outlook)

March 2025 | 241 pages | ID: G01699C5CE0FEN
Bosson Research

Abstracts

Report Overview

Pharmaceutical excipients are the inactive substances that are added to a drug formulation to improve its stability, bioavailability, palatability, and other properties. They are generally regarded as safe (GRAS) by regulatory agencies and are used in various dosage forms, such as tablets, capsules, oral liquids, topical creams, and inhalers.

This report provides a deep insight into the global Pharmaceutical Excipients for Non-injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmaceutical Excipients for Non-injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmaceutical Excipients for Non-injection market in any manner.

Global Pharmaceutical Excipients for Non-injection Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Dow

Nippon Fine Chemical

Nanjing Well Pharmaceutical

Jiangsu Maxim Biological

NOF

Croda

Jiangsu Poly Pharmaceutical

Er Kang Pharmaceutical

Guangzhou Hanfang Pharmaceutical

Pfanstiehl

Xi'an Libang Pharmaceutical

Zhejiang Tianyushan Medicinal Oil

Market Segmentation (by Type)

Binders

Disintegrants

Lubricants

Fillers

Others

Market Segmentation (by Application)

Tablets

Capsules

Oral Liquids

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pharmaceutical Excipients for Non-injection Market
• Overview of the regional outlook of the Pharmaceutical Excipients for Non-injection Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmaceutical Excipients for Non-injection Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Pharmaceutical Excipients for Non-injection
1.2 Key Market Segments
  1.2.1 Pharmaceutical Excipients for Non-injection Segment by Type
  1.2.2 Pharmaceutical Excipients for Non-injection Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Pharmaceutical Excipients for Non-injection Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Pharmaceutical Excipients for Non-injection Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Pharmaceutical Excipients for Non-injection Product Life Cycle
3.3 Global Pharmaceutical Excipients for Non-injection Sales by Manufacturers (2020-2025)
3.4 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Manufacturers (2020-2025)
3.5 Pharmaceutical Excipients for Non-injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pharmaceutical Excipients for Non-injection Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Pharmaceutical Excipients for Non-injection Manufacturing Sites, Area Served, Product Type
3.8 Pharmaceutical Excipients for Non-injection Market Competitive Situation and Trends
  3.8.1 Pharmaceutical Excipients for Non-injection Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Pharmaceutical Excipients for Non-injection Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION INDUSTRY CHAIN ANALYSIS

4.1 Pharmaceutical Excipients for Non-injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Pharmaceutical Excipients for Non-injection Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Pharmaceutical Excipients for Non-injection Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION MARKET BY REGION

6.1 Global Pharmaceutical Excipients for Non-injection Market Size by Region
  6.1.1 Global Pharmaceutical Excipients for Non-injection Market Size by Region
  6.1.2 Global Pharmaceutical Excipients for Non-injection Market Size Market Share by Region
6.2 Global Pharmaceutical Excipients for Non-injection Sales by Region
  6.2.1 Global Pharmaceutical Excipients for Non-injection Sales by Region
  6.2.2 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Pharmaceutical Excipients for Non-injection Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Pharmaceutical Excipients for Non-injection Market Size by Type
7.3 North America Pharmaceutical Excipients for Non-injection Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Pharmaceutical Excipients for Non-injection Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Pharmaceutical Excipients for Non-injection Market Size by Type
8.3 Europe Pharmaceutical Excipients for Non-injection Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size by Type
9.3 Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Pharmaceutical Excipients for Non-injection Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Pharmaceutical Excipients for Non-injection Market Size by Type
10.3 South America Pharmaceutical Excipients for Non-injection Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size by Type
11.3 Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size by Application

12 PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION MARKET PRODUCTION BY REGION

12.1 Global Production of Pharmaceutical Excipients for Non-injection by Region(2020-2025)
12.2 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2020-2025)
12.3 Global Pharmaceutical Excipients for Non-injection Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Pharmaceutical Excipients for Non-injection Production
  12.4.1 North America Pharmaceutical Excipients for Non-injection Production Growth Rate (2020-2025)
  12.4.2 North America Pharmaceutical Excipients for Non-injection Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Pharmaceutical Excipients for Non-injection Production
  12.5.1 Europe Pharmaceutical Excipients for Non-injection Production Growth Rate (2020-2025)
  12.5.2 Europe Pharmaceutical Excipients for Non-injection Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Pharmaceutical Excipients for Non-injection Production (2020-2025)
  12.6.1 Japan Pharmaceutical Excipients for Non-injection Production Growth Rate (2020-2025)
  12.6.2 Japan Pharmaceutical Excipients for Non-injection Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Pharmaceutical Excipients for Non-injection Production (2020-2025)
  12.7.1 China Pharmaceutical Excipients for Non-injection Production Growth Rate (2020-2025)
  12.7.2 China Pharmaceutical Excipients for Non-injection Production, Revenue, Price and Gross Margin (2020-2025)

13 PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2020-2033)
13.3 Global Pharmaceutical Excipients for Non-injection Market Size Market Share by Type (2020-2033)
13.4 Global Pharmaceutical Excipients for Non-injection Price by Type (2020-2033)

14 PHARMACEUTICAL EXCIPIENTS FOR NON-INJECTION MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Pharmaceutical Excipients for Non-injection Market Sales by Application (2020-2033)
14.3 Global Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application (2020-2033)
14.4 Global Pharmaceutical Excipients for Non-injection Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Dow
  15.1.1 Dow Basic Information
  15.1.2 Dow Pharmaceutical Excipients for Non-injection Product Overview
  15.1.3 Dow Pharmaceutical Excipients for Non-injection Product Market Performance
  15.1.4 Dow Business Overview
  15.1.5 Dow SWOT Analysis
  15.1.6 Dow Recent Developments
15.2 Nippon Fine Chemical
  15.2.1 Nippon Fine Chemical Basic Information
  15.2.2 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Overview
  15.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Market Performance
  15.2.4 Nippon Fine Chemical Business Overview
  15.2.5 Nippon Fine Chemical SWOT Analysis
  15.2.6 Nippon Fine Chemical Recent Developments
15.3 Nanjing Well Pharmaceutical
  15.3.1 Nanjing Well Pharmaceutical Basic Information
  15.3.2 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Overview
  15.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Market Performance
  15.3.4 Nanjing Well Pharmaceutical Business Overview
  15.3.5 Nanjing Well Pharmaceutical SWOT Analysis
  15.3.6 Nanjing Well Pharmaceutical Recent Developments
15.4 Jiangsu Maxim Biological
  15.4.1 Jiangsu Maxim Biological Basic Information
  15.4.2 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Overview
  15.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Market Performance
  15.4.4 Jiangsu Maxim Biological Business Overview
  15.4.5 Jiangsu Maxim Biological Recent Developments
15.5 NOF
  15.5.1 NOF Basic Information
  15.5.2 NOF Pharmaceutical Excipients for Non-injection Product Overview
  15.5.3 NOF Pharmaceutical Excipients for Non-injection Product Market Performance
  15.5.4 NOF Business Overview
  15.5.5 NOF Recent Developments
15.6 Croda
  15.6.1 Croda Basic Information
  15.6.2 Croda Pharmaceutical Excipients for Non-injection Product Overview
  15.6.3 Croda Pharmaceutical Excipients for Non-injection Product Market Performance
  15.6.4 Croda Business Overview
  15.6.5 Croda Recent Developments
15.7 Jiangsu Poly Pharmaceutical
  15.7.1 Jiangsu Poly Pharmaceutical Basic Information
  15.7.2 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Overview
  15.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Market Performance
  15.7.4 Jiangsu Poly Pharmaceutical Business Overview
  15.7.5 Jiangsu Poly Pharmaceutical Recent Developments
15.8 Er Kang Pharmaceutical
  15.8.1 Er Kang Pharmaceutical Basic Information
  15.8.2 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Overview
  15.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Market Performance
  15.8.4 Er Kang Pharmaceutical Business Overview
  15.8.5 Er Kang Pharmaceutical Recent Developments
15.9 Guangzhou Hanfang Pharmaceutical
  15.9.1 Guangzhou Hanfang Pharmaceutical Basic Information
  15.9.2 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Overview
  15.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Market Performance
  15.9.4 Guangzhou Hanfang Pharmaceutical Business Overview
  15.9.5 Guangzhou Hanfang Pharmaceutical Recent Developments
15.10 Pfanstiehl
  15.10.1 Pfanstiehl Basic Information
  15.10.2 Pfanstiehl Pharmaceutical Excipients for Non-injection Product Overview
  15.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Product Market Performance
  15.10.4 Pfanstiehl Business Overview
  15.10.5 Pfanstiehl Recent Developments
15.11 Xi'an Libang Pharmaceutical
  15.11.1 Xi'an Libang Pharmaceutical Basic Information
  15.11.2 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Overview
  15.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Market Performance
  15.11.4 Xi'an Libang Pharmaceutical Business Overview
  15.11.5 Xi'an Libang Pharmaceutical Recent Developments
15.12 Zhejiang Tianyushan Medicinal Oil
  15.12.1 Zhejiang Tianyushan Medicinal Oil Basic Information
  15.12.2 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Overview
  15.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Market Performance
  15.12.4 Zhejiang Tianyushan Medicinal Oil Business Overview
  15.12.5 Zhejiang Tianyushan Medicinal Oil Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pharmaceutical Excipients for Non-injection Market Size by Type (M USD)
Table 4. Global Pharmaceutical Excipients for Non-injection Market Size by Application (M USD)
Table 5. Pharmaceutical Excipients for Non-injection Market Size Comparison by Region (M USD)
Table 6. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pharmaceutical Excipients for Non-injection Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pharmaceutical Excipients for Non-injection Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipients for Non-injection as of 2024)
Table 11. Global Market Pharmaceutical Excipients for Non-injection Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Pharmaceutical Excipients for Non-injection Manufacturing Sites and Area Served
Table 13. Manufacturers Pharmaceutical Excipients for Non-injection Product Type
Table 14. Global Pharmaceutical Excipients for Non-injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmaceutical Excipients for Non-injection Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Pharmaceutical Excipients for Non-injection Market Size Comparison by Region (M USD)
Table 26. Global Pharmaceutical Excipients for Non-injection Market Size by Region (2020-2033) & (M USD)
Table 27. Global Pharmaceutical Excipients for Non-injection Market Size Market Share by Region (2020-2033)
Table 28. Global Pharmaceutical Excipients for Non-injection Sales by Region (2020-2033) & (K Units)
Table 29. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2020-2033)
Table 30. North America Pharmaceutical Excipients for Non-injection Market Size by Country (2020-2033) & (M USD)
Table 31. North America Pharmaceutical Excipients for Non-injection Sales by Country (2020-2033) & (K Units)
Table 32. North America Pharmaceutical Excipients for Non-injection Sales by Type (K Units)
Table 33. North America Pharmaceutical Excipients for Non-injection Market Size by Type (M USD)
Table 34. North America Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2020-2033)
Table 35. North America Pharmaceutical Excipients for Non-injection Market Size (M USD) by Type (2020-2033)
Table 36. North America Pharmaceutical Excipients for Non-injection Sales by Application (K Units)
Table 37. North America Pharmaceutical Excipients for Non-injection Market Size by Application (M USD)
Table 38. North America Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2020-2033)
Table 39. North America Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application (2020-2033)
Table 40. Europe Pharmaceutical Excipients for Non-injection Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2020-2033) & (K Units)
Table 42. Europe Pharmaceutical Excipients for Non-injection Sales by Type (K Units)
Table 43. Europe Pharmaceutical Excipients for Non-injection Market Size by Type (M USD)
Table 44. Europe Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2020-2033)
Table 45. Europe Pharmaceutical Excipients for Non-injection Market Size (M USD) by Type (2020-2033)
Table 46. Europe Pharmaceutical Excipients for Non-injection Sales by Application (K Units)
Table 47. Europe Pharmaceutical Excipients for Non-injection Market Size by Application (M USD)
Table 48. Europe Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2020-2033)
Table 49. Europe Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Pharmaceutical Excipients for Non-injection Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Pharmaceutical Excipients for Non-injection Sales by Type (K Units)
Table 53. Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size by Type (M USD)
Table 54. Asia-Pacific Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Pharmaceutical Excipients for Non-injection Sales by Application (K Units)
Table 57. Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size by Application (M USD)
Table 58. Asia-Pacific Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application (2020-2025)
Table 60. South America Pharmaceutical Excipients for Non-injection Market Size by Country (2020-2033) & (M USD)
Table 61. South America Pharmaceutical Excipients for Non-injection Sales by Country (2020-2033) & (K Units)
Table 62. South America Pharmaceutical Excipients for Non-injection Sales by Type (K Units)
Table 63. South America Pharmaceutical Excipients for Non-injection Market Size by Type (M USD)
Table 64. South America Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2020-2033)
Table 65. South America Pharmaceutical Excipients for Non-injection Market Size (M USD) by Type (2020-2033)
Table 66. South America Pharmaceutical Excipients for Non-injection Sales by Application (K Units)
Table 67. South America Pharmaceutical Excipients for Non-injection Market Size by Application (M USD)
Table 68. South America Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2020-2033)
Table 69. South America Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales by Type (K Units)
Table 73. Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size by Type (M USD)
Table 74. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales by Application (K Units)
Table 77. Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size by Application (M USD)
Table 78. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application (2020-2033)
Table 80. Global Pharmaceutical Excipients for Non-injection Production (K Units) by Region(2020-2025)
Table 81. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2020-2025)
Table 83. Global Pharmaceutical Excipients for Non-injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Pharmaceutical Excipients for Non-injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Pharmaceutical Excipients for Non-injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Pharmaceutical Excipients for Non-injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Pharmaceutical Excipients for Non-injection Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Pharmaceutical Excipients for Non-injection Sales by Type (K Units)
Table 89. Global Pharmaceutical Excipients for Non-injection Market Size by Type (M USD)
Table 90. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2020-2033)
Table 91. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2020-2033)
Table 92. Global Pharmaceutical Excipients for Non-injection Market Size (M USD) by Type (2020-2033)
Table 93. Global Pharmaceutical Excipients for Non-injection Market Size Share by Type (2020-2033)
Table 94. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Application
Table 95. Global Pharmaceutical Excipients for Non-injection Market Size by Application(M USD)
Table 96. Global Pharmaceutical Excipients for Non-injection Sales by Application (2020-2033) & (K Units)
Table 97. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2020-2033)
Table 98. Global Pharmaceutical Excipients for Non-injection Market Size by Application (2020-2033) & (M USD)
Table 99. Global Pharmaceutical Excipients for Non-injection Market Share by Application (2020-2033)
Table 100. Global Pharmaceutical Excipients for Non-injection Sales Growth Rate by Application (2020-2033)
Table 101. Dow Basic Information
Table 102. Dow Pharmaceutical Excipients for Non-injection Product Overview
Table 103. Dow Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Dow Business Overview
Table 105. Dow SWOT Analysis
Table 106. Dow Recent Developments
Table 107. Nippon Fine Chemical Basic Information
Table 108. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Overview
Table 109. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Nippon Fine Chemical Business Overview
Table 111. Nippon Fine Chemical SWOT Analysis
Table 112. Nippon Fine Chemical Recent Developments
Table 113. Nanjing Well Pharmaceutical Basic Information
Table 114. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Overview
Table 115. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Nanjing Well Pharmaceutical Business Overview
Table 117. Nanjing Well Pharmaceutical SWOT Analysis
Table 118. Nanjing Well Pharmaceutical Recent Developments
Table 119. Jiangsu Maxim Biological Basic Information
Table 120. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Overview
Table 121. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Jiangsu Maxim Biological Business Overview
Table 123. Jiangsu Maxim Biological Recent Developments
Table 124. NOF Basic Information
Table 125. NOF Pharmaceutical Excipients for Non-injection Product Overview
Table 126. NOF Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. NOF Business Overview
Table 128. NOF Recent Developments
Table 129. Croda Basic Information
Table 130. Croda Pharmaceutical Excipients for Non-injection Product Overview
Table 131. Croda Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Croda Business Overview
Table 133. Croda Recent Developments
Table 134. Jiangsu Poly Pharmaceutical Basic Information
Table 135. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Overview
Table 136. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Jiangsu Poly Pharmaceutical Business Overview
Table 138. Jiangsu Poly Pharmaceutical Recent Developments
Table 139. Er Kang Pharmaceutical Basic Information
Table 140. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Overview
Table 141. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Er Kang Pharmaceutical Business Overview
Table 143. Er Kang Pharmaceutical Recent Developments
Table 144. Guangzhou Hanfang Pharmaceutical Basic Information
Table 145. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Overview
Table 146. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Guangzhou Hanfang Pharmaceutical Business Overview
Table 148. Guangzhou Hanfang Pharmaceutical Recent Developments
Table 149. Pfanstiehl Basic Information
Table 150. Pfanstiehl Pharmaceutical Excipients for Non-injection Product Overview
Table 151. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Pfanstiehl Business Overview
Table 153. Pfanstiehl Recent Developments
Table 154. Xi'an Libang Pharmaceutical Basic Information
Table 155. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Overview
Table 156. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Xi'an Libang Pharmaceutical Business Overview
Table 158. Xi'an Libang Pharmaceutical Recent Developments
Table 159. Zhejiang Tianyushan Medicinal Oil Basic Information
Table 160. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Overview
Table 161. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Zhejiang Tianyushan Medicinal Oil Business Overview
Table 163. Zhejiang Tianyushan Medicinal Oil Recent Developments
List of Figures
Figure 1. Product Picture of Pharmaceutical Excipients for Non-injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmaceutical Excipients for Non-injection Market Size (M USD), 2024-2033
Figure 5. Global Pharmaceutical Excipients for Non-injection Market Size (M USD) (2020-2033)
Figure 6. Global Pharmaceutical Excipients for Non-injection Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmaceutical Excipients for Non-injection Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pharmaceutical Excipients for Non-injection Product Life Cycle
Figure 13. Pharmaceutical Excipients for Non-injection Sales Share by Manufacturers in 2024
Figure 14. Global Pharmaceutical Excipients for Non-injection Revenue Share by Manufacturers in 2024
Figure 15. Pharmaceutical Excipients for Non-injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Pharmaceutical Excipients for Non-injection Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Excipients for Non-injection Revenue in 2024
Figure 18. Industry Chain Map of Pharmaceutical Excipients for Non-injection
Figure 19. Global Pharmaceutical Excipients for Non-injection Market PEST Analysis
Figure 20. Global Pharmaceutical Excipients for Non-injection Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Pharmaceutical Excipients for Non-injection Market Size by Region
Figure 27. Global Pharmaceutical Excipients for Non-injection Market Size Market Share by Region (2020-2033)
Figure 28. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Pharmaceutical Excipients for Non-injection Market Size (M USD) by Country
Figure 33. USA Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Pharmaceutical Excipients for Non-injection Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Pharmaceutical Excipients for Non-injection Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Pharmaceutical Excipients for Non-injection Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Pharmaceutical Excipients for Non-injection Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Pharmaceutical Excipients for Non-injection Market Size (M USD)by Type
Figure 40. North America Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Pharmaceutical Excipients for Non-injection Market Size (M USD) by Country
Figure 45. Germany Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Pharmaceutical Excipients for Non-injection Market Size (M USD) by Type
Figure 56. Europe Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size (M USD) by Country
Figure 61. China Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size (M USD) by Type
Figure 72. Asia-Pacific Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Pharmaceutical Excipients for Non-injection Market Size (M USD) by Country
Figure 77. Brazil Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Pharmaceutical Excipients for Non-injection Market Size (M USD) by Type
Figure 84. South America Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size (M USD) by Country
Figure 89. Saudi Arabia Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Pharmaceutical Excipients for Non-injection Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Pharmaceutical Excipients for Non-injection Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size (M USD) by Type
Figure 100. Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size (M USD) by Application
Figure 101. Global Pharmaceutical Excipients for Non-injection Production Market Share by Region (2020-2025)
Figure 102. North America Pharmaceutical Excipients for Non-injection Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Pharmaceutical Excipients for Non-injection Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Pharmaceutical Excipients for Non-injection Production (K Units) Growth Rate (2020-2025)
Figure 105. China Pharmaceutical Excipients for Non-injection Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Pharmaceutical Excipients for Non-injection Market Size by Type (M USD)
Figure 108. Sales Market Share of Pharmaceutical Excipients for Non-injection by Type (2020-2033)
Figure 109. Sales Market Share of Pharmaceutical Excipients for Non-injection by Type in 2024
Figure 110. Market Size Share of Pharmaceutical Excipients for Non-injection by Type (2020-2033)
Figure 111. Market Size Share of Pharmaceutical Excipients for Non-injection by Type in 2024
Figure 112. Global Pharmaceutical Excipients for Non-injection Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Pharmaceutical Excipients for Non-injection Market Size by Application(M USD)
Figure 115. Global Pharmaceutical Excipients for Non-injection Market Share by Application
Figure 116. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2020-2033)
Figure 117. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application in 2024
Figure 118. Global Pharmaceutical Excipients for Non-injection Market Share by Application (2020-2033)
Figure 119. Global Pharmaceutical Excipients for Non-injection Market Share by Application in 2024
Figure 120. Global Pharmaceutical Excipients for Non-injection Sales Growth Rate by Application (2020-2033)